Chimeric Proteins Composed of Jun and CREB Define Domains

Total Page:16

File Type:pdf, Size:1020Kb

Chimeric Proteins Composed of Jun and CREB Define Domains JOURNAL OF VIROLOGY, Oct. 1995, p. 6209–6218 Vol. 69, No. 10 0022-538X/95/$04.0010 Copyright q 1995, American Society for Microbiology Chimeric Proteins Composed of Jun and CREB Define Domains Required for Interaction with the Human T-Cell Leukemia Virus Type 1 Tax Protein MIN JEAN YIN, EVYIND PAULSSEN, JACOB SEELER,† AND RICHARD B. GAYNOR* Departments of Internal Medicine and Microbiology, Divisions of Molecular Virology and Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-8594 Received 5 April 1995/Accepted 26 June 1995 The regulation of human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat gene expression is dependent on three cis-acting elements known as 21-bp repeats and the transactivator protein Tax. Mutagen- esis has demonstrated that sequences in each of the 21-bp repeats can be divided into three domains designated A, B, and C. Tax stimulates the binding of CREB to the B domain, which is essential for Tax activation of HTLV-1 gene expression. In this study, we demonstrate that Tax will stimulate the binding of CREB to the HTLV-1 21-bp repeats but does not stimulate CREB binding to the consensus cyclic AMP response element (CRE) element found in the somatostatin promoter. However, Tax stimulates CREB binding to a consensus CRE in the context of the 21-bp repeats, indicating the importance of these sequences in stimulating CREB binding. To determine the mechanism by which Tax stimulates CREB binding and determine potential interactions between Tax and CREB, we used the mammalian two-hybrid system in conjunction with in vitro binding and gel retardation assays. Two-hybrid analysis indicated that mutations in either the basic or leucine zipper region of CREB prevented interactions with Tax. Since several studies have demonstrated that Tax will also stimulate the binding of a variety of different basic region-leucine zipper proteins to their cognate binding sites, we assayed whether chimeric proteins composed of portions of CREB and another basic region-leucine zipper protein, Jun, could be used to map domains required for interactions with Tax. These studies were possible because we did not detect in vivo or in vitro interactions between Tax and Jun. The amino acid sequence of the CREB basic region and a portion of its leucine zipper were required for both in vivo and in vitro interactions with Tax and increased binding of CREB to the 21-bp repeats in response to Tax. These studies define the domains in CREB required for both in vivo and in vitro interactions by the HTLV-1 Tax protein. Human T-cell leukemia virus type 1 (HTLV-1) is a human strated to bind members of the ATF/CREB family of transcrip- retrovirus which is the etiologic agent of adult T-cell leukemia/ tion factors (4, 5, 59, 62, 65–67). The B motif mediates tran- lymphoma (33, 47, 63) and a degenerative neurologic syn- scriptional activation of HTLV-1 gene expression in response drome designated tropical spastic paraparesis (28, 44). to both Tax (27, 29, 41, 51, 60) and increases in cAMP (36, 48) HTLV-1 encodes a 40-kDa transactivator protein, Tax, which levels, indicating that cellular factors that bind to the CRE is critical for modulating HTLV-1 gene expression (9, 13, 16, such as CREB are likely critical for regulating gene expression 24, 58) and is also involved in the cellular transformation by from the 21-bp repeats. However, Tax activation of other viral HTLV-1 (32, 61). In addition, Tax also activates the expression and cellular promoters is mediated by factors that bind to sites of several other viral and cellular genes, including interleu- that are different from that of the 21-bp repeats. For example, kin-2, interleukin-2 receptor a,c-fos, and those of human im- Tax activation of the interleukin-2 receptor a (12, 35, 38) and munodeficiency type 1 (20, 21, 22, 35, 38), and also suppresses the human immunodeficiency virus LTR (7, 53, 56, 58) is the expression of the DNA polymerase b gene (37). Thus, Tax mediated by NF-kB sites (14, 16) and Tax activation of the is a relatively permissive viral transactivator which can modu- c-fos promoter is mediated by serum response factor sites (20, late the expression of both viral and cellular genes. 21). Thus, Tax may either directly or indirectly interact with a The HTLV-1 long terminal repeat (LTR) contains three variety of different transcription factors to alter the level of cis-acting regulatory elements designated 21-bp repeats which gene expression from tax-responsive genes. are necessary for transactivation by Tax (8, 25, 46, 55). The Tax activation of HTLV-1 gene expression is not due to its 21-bp repeats have been further subdivided into three motifs direct binding to the HTLV-1 LTR (5, 26, 29, 40). Instead, Tax designated A, B, and C (27, 41, 45). The B motif in each of the has been demonstrated to interact with cellular factors which 21-bp repeats contains the core sequence TGACG, which is are able to bind to the HTLV-1 LTR, including members of designated the tax response element and is very homologous to the ATF/CREB family (2, 4, 19, 45, 59, 62, 66, 67), HEB1 (6), sequences found in cellular genes which contain cyclic AMP and TFIID (10). Tax stimulates the binding of CREB to the B (cAMP) response elements (CREs) and have been demon- motif within the 21-bp repeats (19, 62, 67) in gel retardation analysis, though results have differed on whether this associa- tion is stable during electrophoresis (2, 4, 19, 45, 62, 64, 66, 67). * Corresponding author. Mailing address: Division of Molecular Other studies have demonstrated that Tax is able to stimulate Virology, Department of Internal Medicine, Southwestern Medical Center, Harry Hines Blvd., Dallas, TX 75235-8594. Phone: (214) 648- the binding of a variety of different basic region-leucine zipper 7570. Fax: (214) 648-8862. (bZIP) proteins to their cognate binding sites, using gel retar- † Present address: Unite´ de Recombinaison et Expression dation assays (4, 19, 62). It is unclear how this permissive effect Ge´ne´tique, Institut Pasteur, Paris, France. of Tax on the binding of multiple bZIP proteins can be corre- 6209 6210 YIN ET AL. J. VIROL. lated with the restricted ability of Tax to activate viral and The bacterial expression vectors pGEX-2T and pQE60 with either Tax or CREB cellular promoters (27, 45). Previously, we characterized the cDNA inserts were transformed into Escherichia coli M15; 400-ml cultures of E. coli were grown to an optical density at 600 nm of 0.6 to 0.8 and induced with 0.1 determinants of Tax interaction with members of the ATF/ mM isopropylthiogalactopyranoside (IPTG) for 3 h. Cells were pelleted, resus- CREB family, using both in vivo and in vitro assays, and dem- pended in buffer A (50 mM Tris-HCl [pH 8.0], 100 mM NaCl, 0.1 mM phenyl- onstrated that Tax specifically interacted with CREB but not methylsulfonyl fluoride), and mildly sonicated, and the debris was pelleted. For another member of the ATF/CREB family, CRE-BP1, nor the GST fusion proteins, the supernatant was incubated with 1 ml of glutathione- Sepharose beads (Sigma) for 60 min at 48C. The beads were then washed five bZIP protein Jun (64). In the current study, we further char- times with 10 ml of buffer A containing 1% Triton X-100. The proteins were acterize domains within CREB which are required for the eluted by incubation with elution buffer (50 mM Tris-HCl [pH 8.0], 100 mM interaction with Tax, using both site-directed mutagenesis and NaCl, 1 mM dithiothreitol, 1 mM EDTA) containing 10 mM glutathione at 48C. chimeric proteins composed of chimeric CREB and different Proteins were dialyzed against protein storage buffer (10 mM Tris-HCl [pH 8.0], 50 mM NaCl, 10% glycerol, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl domains of the bZIP protein Jun. These CREB proteins were fluoride) and were stored at 2808C. For 63His-tagged proteins, bacterial cells assayed by using gel retardation in the presence and absence of were cultured and fractionated under the same conditions except that the cell Tax, in in vitro binding assays with Tax, and in two-hybrid lysate was incubated with 1 ml of Ni-nitrilotriacetate agarose (Qiagen) for 60 min analysis. Our results suggest that the primary amino acid se- at 48C. The proteins were eluted with elution buffer containing from 150 to 500 mM imidazole. The proteins were dialyzed against protein storage buffer and quence of both the CREB basic domain and a portion of the kept at 2808C. leucine zipper region and the ability of CREB to form protein Gel retardation analysis. For gel retardation assays, 50 to 100 ng each of dimers are critical for Tax interaction and Tax stimulation of bacterially produced CREB-63His and the CREB-63His mutants in either the CREB binding to the HTLV-1 21-bp repeats. presence or absence of bacterially produced Tax-63His proteins was incubated with 1 mg of poly(dI-dC) (Pharmacia) and 50,000 cpm of labeled probe in binding buffer (10 mM Tris-HCl [pH 7.4], 1 mM EDTA, 1 mM dithiothreitol, 5% MATERIALS AND METHODS glycerol, 50 mM NaCl). The reaction time was 20 min at room temperature in a 40-ml final volume. Synthetic double-stranded oligonucleotides contained the Plasmid constructs. The 53GAL-E1B TATA-CAT reporter plasmid contain- somatostatin CRE (59-GGTTCCTCCTTGGCTGACGTCAGAGAGAGA-39), ing five GAL4 DNA binding sites and the E1B TATA box linked to the chlor- HTLV-1 LTR 21-bp repeat III (59-TCGACGTCCTCAGGCGTTGACGACAA amphenicol acetyltransferase (CAT) gene has previously been described (50).
Recommended publications
  • Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-Like Mouse Models: Tracking the Role of the Hairless Gene
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2006 Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene Yutao Liu University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Life Sciences Commons Recommended Citation Liu, Yutao, "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino- like Mouse Models: Tracking the Role of the Hairless Gene. " PhD diss., University of Tennessee, 2006. https://trace.tennessee.edu/utk_graddiss/1824 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Yutao Liu entitled "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Life Sciences. Brynn H. Voy, Major Professor We have read this dissertation and recommend its acceptance: Naima Moustaid-Moussa, Yisong Wang, Rogert Hettich Accepted for the Council: Carolyn R.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Genome-Wide Approach to Identify Risk Factors for Therapy-Related Myeloid Leukemia
    Leukemia (2006) 20, 239–246 & 2006 Nature Publishing Group All rights reserved 0887-6924/06 $30.00 www.nature.com/leu ORIGINAL ARTICLE Genome-wide approach to identify risk factors for therapy-related myeloid leukemia A Bogni1, C Cheng2, W Liu2, W Yang1, J Pfeffer1, S Mukatira3, D French1, JR Downing4, C-H Pui4,5,6 and MV Relling1,6 1Department of Pharmaceutical Sciences, The University of Tennessee, Memphis, TN, USA; 2Department of Biostatistics, The University of Tennessee, Memphis, TN, USA; 3Hartwell Center, The University of Tennessee, Memphis, TN, USA; 4Department of Pathology, The University of Tennessee, Memphis, TN, USA; 5Department of Hematology/Oncology St Jude Children’s Research Hospital, The University of Tennessee, Memphis, TN, USA; and 6Colleges of Medicine and Pharmacy, The University of Tennessee, Memphis, TN, USA Using a target gene approach, only a few host genetic risk therapy increases, the importance of identifying host factors for factors for treatment-related myeloid leukemia (t-ML) have been secondary neoplasms increases. defined. Gene expression microarrays allow for a more 4 genome-wide approach to assess possible genetic risk factors Because DNA microarrays interrogate multiple ( 10 000) for t-ML. We assessed gene expression profiles (n ¼ 12 625 genes in one experiment, they allow for a ‘genome-wide’ probe sets) in diagnostic acute lymphoblastic leukemic cells assessment of genes that may predispose to leukemogenesis. from 228 children treated on protocols that included leukemo- DNA microarray analysis of gene expression has been used to genic agents such as etoposide, 13 of whom developed t-ML. identify distinct expression profiles that are characteristic of Expression of 68 probes, corresponding to 63 genes, was different leukemia subtypes.13,14 Studies using this method have significantly related to risk of t-ML.
    [Show full text]
  • Human T-Cell Leukemia Virus Type I Tax Transactivates Human Interleukin 8 Gene Through Acting Concurrently on AP-1 and Nuclear Factor-KB-Like Sites
    [CANCER RESEARCH 58. 3993-4000. September 1. 1998] Human T-Cell Leukemia Virus Type I Tax Transactivates Human Interleukin 8 Gene through Acting Concurrently on AP-1 and Nuclear Factor-KB-like Sites Naoki Mori,1 Naofumi Mukaida, Dean W. Ballard, Kouji Matsushima, and Naoki Vaniamolo Department of Preventive Medicine and AIDS Research. Research Field of Palhogenesis and Clinical Sciences, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852, Japan ¡N.M.. N. YJ; Department of Pharmacology. Cancer Research Institute, Kanazawa University, Kanayiwa 920, Japan ¡N.M.¡:Department of Molecular Preventive Medicine, School of Medicine. University of Tok\o. Tokyo 113, Japan ¡K.M.I: and Howard Hughes Medical Institute. Vanderhilt University School of Medicine. Nashville, Tennessee 37232-0295 [D. W. BJ ABSTRACT unclear but could be one of the common pathological findings among diseases associated with HTLV-I infection. The transactivator protein, Tax, from the human T-cell leukemia virus IL-8 has potent chemotactic activity for T lymphocytes, as well as type I (HTLV-I) transactivates both viral and cellular genes. Previously, neutrophils (1, 2). Interestingly, T lymphocytes are 10-fold more we had shown that interleukin 8 (II.-8) is constitutively expressed in sensitive to IL-8 than neutrophils in chemotaxis (3). Thus, IL-8 is an HTLV-I-infected cells and in cells transiently expressing Tax. We show here that the II -X promoter is Tax responsive in Jurkat T cells. Further important mediator for tissue infiltration of various subsets of leuko more, using several deletion and mutated plasmids of the 5'-flanking cytes (7).
    [Show full text]
  • Interaction of Bovine Leukemia Virus Transactivator Tax with Bzip Proteins
    VIROLOGY 214, 207–214 (1995) Interaction of Bovine Leukemia Virus Transactivator Tax with bZip Proteins IMRE M. BOROS,1 FENG TIE, and CHOU-ZEN GIAM2 Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106 Received June 7, 1995; accepted October 2, 1995 The bovine leukemia virus transactivator, BLV Tax, augments transcription from three imperfect 21-bp repeats in the viral transcriptional regulatory region. Each BLV 21-bp repeat contains a cAMP response element (CRE) in the center and unique 5* and 3* neighboring sequences which are crucial for the transcriptional activation by BLV Tax. Here we describe the interactions of recombinant BLV Tax with cellular bZip proteins. The recombinant BLV Tax, tagged at the carboxy terminus with a hexahistidine extension, was prepared by solubilization in 6 M guanidine hydrochloride and renaturation on the Ni2/- chelating Sepharose gel matrix. The renatured BLV TaxH6 activates the BLV LTR when introduced into HeLa cells by scrape loading. Furthermore, the purified BLV TaxH6 enhances binding of members of the CREB/ATF family of bZip proteins to CRE motifs by interacting with their bZip domains in vitro. Chemical cross-linking indicates that dimerization of bZip proteins such as CREB becomes greatly facilitated in the presence of BLV Tax. These results suggest that BLV Tax interacts directly with CREB/ATF-like factors to activate viral mRNA transcription. q 1995 Academic Press, Inc. INTRODUCTION flanking the CRE dictate the exclusive inducibility of the 3 BLV or HTLV-I 21-bp repeats by the respective Tax pro- Bovine leukemia virus (BLV) and human T-lympho- teins (Fujisawa et al., 1989; Montagne et al., 1990; Paca tropic virus type I (HTLV-I) belong to a group of oncore- Uccaralertkun et al., 1994).
    [Show full text]
  • S12977-020-00538-W.Pdf
    Millen et al. Retrovirology (2020) 17:30 https://doi.org/10.1186/s12977-020-00538-w Retrovirology RESEARCH Open Access A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells Sebastian Millen, Lina Meretuk, Tim Göttlicher, Sarah Schmitt, Bernhard Fleckenstein and Andrea K. Thoma‑Kress* Abstract Background: Human T‑cell leukemia virus type 1 (HTLV‑1) infects primarily CD4+ T‑lymphocytes and evoques severe diseases, predominantly Adult T‑Cell Leukemia/ Lymphoma (ATL/L) and HTLV‑1‑associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP). The viral transactivator of the pX region (Tax) is important for initiating malignant transformation, and deregulation of the major signaling pathway nuclear factor of kappa B (NF‑κB) by Tax represents a hallmark of HTLV‑1 driven cancer. Results: Here we found that Tax mutants which are defective in NF‑κB signaling showed diminished protein expres‑ sion levels compared to Tax wildtype in T‑cells, whereas Tax transcript levels were comparable. Strikingly, constant activation of NF‑κB signaling by the constitutive active mutant of inhibitor of kappa B kinase (IKK2, IKK‑β), IKK2‑EE, rescued protein expression of the NF‑κB defective Tax mutants M22 and K1‑10R and even increased protein levels of Tax wildtype in various T‑cell lines while Tax transcript levels were only slightly afected. Using several Tax expres‑ sion constructs, an increase of Tax protein occurred independent of Tax transcripts and independent of the promoter used. Further, Tax and M22 protein expression were strongly enhanced by 12‑O‑Tetradecanoylphorbol‑13‑Acetate [TPA; Phorbol 12‑myristate 13‑acetate (PMA)]/ ionomycin, inducers of NF‑κB and cytokine signaling, but not by tumor necrosis factor alpha (TNF‑α).
    [Show full text]
  • Transcriptional and Post-Transcriptional Regulation of ATP-Binding Cassette Transporter Expression
    Transcriptional and Post-transcriptional Regulation of ATP-binding Cassette Transporter Expression by Aparna Chhibber DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Pharmaceutical Sciences and Pbarmacogenomies in the Copyright 2014 by Aparna Chhibber ii Acknowledgements First and foremost, I would like to thank my advisor, Dr. Deanna Kroetz. More than just a research advisor, Deanna has clearly made it a priority to guide her students to become better scientists, and I am grateful for the countless hours she has spent editing papers, developing presentations, discussing research, and so much more. I would not have made it this far without her support and guidance. My thesis committee has provided valuable advice through the years. Dr. Nadav Ahituv in particular has been a source of support from my first year in the graduate program as my academic advisor, qualifying exam committee chair, and finally thesis committee member. Dr. Kathy Giacomini graciously stepped in as a member of my thesis committee in my 3rd year, and Dr. Steven Brenner provided valuable input as thesis committee member in my 2nd year. My labmates over the past five years have been incredible colleagues and friends. Dr. Svetlana Markova first welcomed me into the lab and taught me numerous laboratory techniques, and has always been willing to act as a sounding board. Michael Martin has been my partner-in-crime in the lab from the beginning, and has made my days in lab fly by. Dr. Yingmei Lui has made the lab run smoothly, and has always been willing to jump in to help me at a moment’s notice.
    [Show full text]
  • The Internal Methionine Codons of Human T-Cellleukemia Virus Type
    JOURNAL OF VIROLOGY, Oct. 1990, p. 4914-4921 Vol. 64, No. 10 0022-538X/90/104914-08$02.00/0 Copyright C) 1990, American Society for Microbiology The Internal Methionine Codons of Human T-Cell Leukemia Virus Type II rex Gene Are Not Required for p24rex Production or Virus Replication and Transformation PATRICK L. GREEN,' YIMING XIE,' AND IRVIN S. Y. CHEN' 2* Division of Hematology-Oncology, Department of Medicine,' and Department of Microbiology and Immunology,2 UCLA School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, California 90024-1736 Received 21 May 1990/Accepted 12 July 1990 Human T-cell leukemia virus types I (HTLV-I) and II (HTLV-II) have two nonstructural trans-acting regulatory genes, tax and rex, located in the 3' region of the viral genome. The tax gene product (HTLV-I p4O't and HTLV-II p37) is the transcriptional activator of the viral long terminal repeat. The rex gene encodes two protein products, p27rex/p2lrex and p26`ex/p24rex in HTLV-I and HTLV-II, respectively. Rex acts posttran- scriptionally to facilitate accumulation of full-length gaglpol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells. Previous studies showed that the first ATG of the rex gene is critical for Rex production and function. The importance of the internal ATGs to Rex function is not known. However, in vitro mutagenesis of the HTLV-I rex gene has provided indirect evidence which suggests that p2lrex, and by analogy HTLV-II p24rex, results from initiation at an internal AUG of the taxlrex mRNA.
    [Show full text]
  • Transcription Profile of Cells Infected with Human T-Cell Leukemia Virus Type I Compared with Activated Lymphocytes1
    [CANCER RESEARCH 62, 3562–3571, June 15, 2002] Transcription Profile of Cells Infected with Human T-cell Leukemia Virus Type I Compared with Activated Lymphocytes1 Cynthia A. Pise-Masison, Michael Radonovich, Renaud Mahieux, Pramita Chatterjee, Craig Whiteford, Janet Duvall, Claire Guillerm, Antoine Gessain, and John N. Brady2 Basic Research Laboratory, Virus Tumor Biology Section, National Cancer Institute, Bethesda, Maryland 20892 [C. A. P-M., M. R., P. C., J. D., C. G., J. N. B.]; Unite d’Epidemiologie et Physiopathologie des Virus Oncogenes, Batiment SIDA-Retrovirus, Institut Pasteur, 75724, Cedex 15, Paris, France [R. M., A. G.]; and Advanced Technology Center, National Institutes of Health, Gaithersburg, Maryland [C. W.] ABSTRACT vivo for viral infectivity and replication (12–16). In addition, the p12 protein has been implicated in the MHC class I-mediated immune Human T-cell leukemia virus type I (HTLV-I) is the etiologic agent for response and T-cell signaling (16–18). The viral protein p13 has also adult T-cell leukemia and the neurological disorder tropical spastic para- recently been reported to regulate cellular signaling pathways (19). -paresis/HTLV-I-associated myelopathy. CD4؉ T lymphocytes, the pri mary hosts for HTLV-I, undergo a series of changes that lead to T-cell Finally, the p30 protein is reported to play a role in transcriptional activation, immortalization, and transformation. To gain insight into the regulation with the use of Gal4-p30 fusion constructs (20). genetic differences between activated and HTLV-I-infected lymphocytes, DNA microarray technology has facilitated the development of a we performed Affymetrix GeneChip analysis of activated and HTLV-I- more complete and inclusive analysis of gene expression profiles in infected cells.
    [Show full text]
  • Supp Data.Pdf
    Supplementary Methods Verhaak sub-classification The Verhaak called tumor subtype was assigned as determined in the Verhaak et al. manuscript, for those TCGA tumors that were included at the time. TCGA data for expression (Affymetrix platform, level 1) and methylation (Infinium platform level 3) were downloaded from the TCGA portal on 09/29/2011. Affymetrix data were processed using R and Biocondutor with a RMA algorithm using quantile normalization and custom CDF. Level 3 methylation data has already been processed and converted to a beta-value. The genes that make up the signature for each of the 4 Verhaak groups (i.e. Proneural, Neural, Mesenchymal, and Classical) were downloaded. For each tumor, the averaged expression of the 4 genes signatures was calculated generating 4 ‘metagene’ scores, one for each subtype, (Colman et al.2010) for every tumor. Then each subtype metagene score was z-score corrected to allow comparison among the 4 metagenes. Finally, for each tumor the subtype with the highest metagene z-score among the four was used to assign subtype. Thus by this method, a tumor is assigned to the group to which it has the strongest expression signature. The shortcoming is that if a tumor has a ‘dual personality’ – for instance has strong expression of both classical and mesenchymal signature genes, there is some arbitrariness to the tumor’s assignment. Western Blot Analysis and cell fractionation Western blot analysis was performed using standard protocols. To determine protein expression we used the following antibodies: TAZ (Sigma and BD Biosciences), YAP (Santa Cruz Biotechnology), CD44 (Cell Signaling), FN1 (BD Biosciences), TEAD1, TEAD2, TEAD3, TEAD4 (Santa Cruz Biotechnology), MST1, p-MST1, MOB1, LATS1, LATS2, 14-3-3-, 1 ACTG2, (Cell Signaling), p-LATS1/2 (Abcam), Flag (Sigma Aldrich), Actin (Calbiochem), CAV2 (BD Biosciences), CTGF (Santa Cruz), RUNX2 (Sigma Aldrich), Cylin A, Cyclin E, Cyclin B1, p-cdk1, p-cdk4 (Cell Signaling Technologies).
    [Show full text]
  • Sequence and Chromatin Determinants of Cell-Type Specific
    Sequence and chromatin determinants of cell-type specific transcription factor binding: supplementary data Aaron Arvey1, Phaedra Agius1, William Stafford Noble2, and Christina Leslie1∗ 1Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 2Department of Genome Sciences, University of Washington, Seattle, WA March 15, 2012 Table S1: List of all TF ChIP-seq experiments analyzed in the study. File name Cell TF wgEncodeYaleChIPseqRawDataRep1Helas3Ap2alpha Helas3 AP2A1 wgEncodeYaleChIPseqRawDataRep2Helas3Ap2alpha Helas3 AP2A1 wgEncodeYaleChIPseqRawDataRep1Helas3Ap2gamma Helas3 TFAP2C wgEncodeYaleChIPseqRawDataRep2Helas3Ap2gamma Helas3 TFAP2C wgEncodeYaleChIPseqRawDataRep1K562Atf3 K562 ATF3 wgEncodeYaleChIPseqRawDataRep2K562Atf3 K562 ATF3 wgEncodeYaleChIPseqRawDataRep1Helas3Baf155Musigg Helas3 SMARCC1 wgEncodeYaleChIPseqRawDataRep2Helas3Baf155Musigg Helas3 SMARCC1 wgEncodeYaleChIPseqRawDataRep1Helas3Baf170Musigg Helas3 SMARCC2 wgEncodeHudsonalphaChipSeqRawDataRep1Gm12878Batf Gm12878 BATF wgEncodeHudsonalphaChipSeqRawDataRep2Gm12878Batf Gm12878 BATF wgEncodeHudsonalphaChipSeqRawDataRep1Gm12878Bcl11a Gm12878 BCL11A wgEncodeHudsonalphaChipSeqRawDataRep2Gm12878Bcl11a Gm12878 BCL11A wgEncodeHudsonalphaChipSeqRawDataRep1Gm12878Bcl3Pcr1xBcl3 Gm12878 BCL3 wgEncodeHudsonalphaChipSeqRawDataRep2Gm12878Bcl3Pcr1xBcl3 Gm12878 BCL3 wgEncodeYaleChIPseqRawDataRep1Helas3Bdp1 Helas3 BDP1 wgEncodeYaleChIPseqRawDataRep2Helas3Bdp1 Helas3 BDP1 wgEncodeYaleChIPseqRawDataRep1K562Bdp1 K562 BDP1 wgEncodeYaleChIPseqRawDataRep2K562Bdp1 K562
    [Show full text]
  • WO 2012/054896 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number ι (43) International Publication Date ¾ ί t 2 6 April 2012 (26.04.2012) WO 2012/054896 Al (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, C12N 5/00 (2006.01) C12N 15/00 (2006.01) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, C12N 5/02 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (21) International Application Number: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, PCT/US201 1/057387 ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (22) International Filing Date: NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, 2 1 October 201 1 (21 .10.201 1) RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (25) Filing Language: English ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 61/406,064 22 October 2010 (22.10.2010) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, 61/415,244 18 November 2010 (18.1 1.2010) US UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, (71) Applicant (for all designated States except US): BIO- DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, TIME INC.
    [Show full text]